Abstract
One and a half decades have gone by since the concept of quantal secretion of neurotransmitter was originally introduced (for refs. see Katz, 1969). The initial work was done on the skeletal neuromuscular endplate, but it appears that the postjunctional membrane potential (MP) in essentially all neuro-effector junctions so far investigated shows extensive similarities to that of the endplate. Thus in the absence of nerve impulses there are spontaneous subthreshold spike-like fluctuations in the MP, similar to the MEPP (miniature endplate potentials) of the neuromuscular endplate, and on nerve stimulation the MP does not rise continuously but in steps, to a level above the resting potential in some instances apparently corresponding to an integral number of the amplitude of a single MEPP. Since focal application of exogenous acetylcholine to the neuromuscular endplate does not produce a stepwise, but a smoothly graded rise in MP, the important conclusion has been drawn that the chemoreceptors of the postjunctional membrane are not enough sensitive to detect, or to signal the detection of, single transmitter molecules. It has thus been postulated that the spontaneous miniature potentials are not due to diffuse leakage of transmitter, but to the impact on the postjunctional membrane of focally secreted multimolecular packets of transmitter, of preset size. The electronmicroscopical findings of vesicular structures accumulating in nerve terminals, and the subsequent demonstration by biochemical techniques that these “synaptic vesicles” are loaded with neurotransmitter, led to the assumption that the transmitter quanta are stored in and secreted from the vesicles, or “transmitter granules”, and that the size of the quantum is possibly determined by their total content of transmitter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Banks, P., Helle, K.: The release of protein from the stimulated adrenal medulla. Biochem. J. 97, 40c (1965).
— — Mayor, D.: Evidence for the presence of a chromogranin-like protein in bovine splenic nerve granules. Molec. Pharmacol. 5, 210–212 (1969).
Blaschko, H., Comline, R. S., Schneider, F. H., Silver, M., Smith, A. D.: Secretion of chromaffine granule protein, chromogranin, from the adrenal gland after splanchnic stimulation. Nature (Lond.) 215, 58–59 (1967)
Burn, J. H., Rand, M. J.: New interpretation of the adrenergic nerve fiber. Advanc. Pharmacol. 7, 1 (1965).
Burnstock, G., Holman, M. E.: The transmission of excitation from autonomie nerve to smooth muscle. J. Physiol. (Lond.) 155, 115–133 (1961).
— — Junction potentials at adrenergic synapses. Pharmacol. Rev. 18, 481–493 (1966).
— — Kuriyama, H.: Facilitation of transmission from autonomic nerve to smooth muscle of guinea-pig vas deferens. J. Physiol. (Lond.) 172, 31–49 (1964).
— Robinson, P. M.: Localization of catecholamine and acetylcholinesterase in autonomic nerves. Circulat. Res. XX–XXI, 43–55 (1967).
Bygdeman, S., V. Euler, U. S., Hökfelt, B.: Resynthesis of adrenaline in the rabbit’s adrenal medulla during insulin-induced hypoglycemia. Acta physiol. scand. 49, 21–28 (1960).
Carlsson, A.: Drugs which block the storage of 5-hydroxytryptamine and related amines. Handbook of experimental pharmacology, XIX, 529–592. Berlin-Heidelberg-New York: Springer 1965.
Davies, B. N., Withrington, P. G.: The release of noradrenaline by the sympathetic postganglionic nerves to the spleen of the cat in response to low frequency stimulation. Arch. int. Pharmacodyn. 171, 185–196 (1968).
De Potter, W. P., De Schaepdryver, A. F., Moerman, E. J., Smith, A. D.: Evidence for the release of vesicle-proteins together with noradrenaline upon stimulation of the splenic nerve. J. Physiol. (Lond.) 1969, 52 p.
Douglas, W. W.: The mechanism of release of catecholamines from the adrenal medulla. 2nd Catecholamine Meeting, Milano, July. Pharmacol. Rev. 18, 471–480 (1965).
— Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. The first gaddum memorial lecture. Brit. J. Pharmacol. 34, 451–474 (1968).
— Kanno, T., Sampson, S. R.: Effects of acetylcholine and other medullary secretagogues and antagonists on the membrane potential of adrenalin chromaffin cells: an analysis employing techniques of tissue culture. J. Physiol. (Lond.) 188, 107–120 (1967).
— Poisner, A. M., Rubin, R. P.: Efflux of adenine nucleotides from perfused adrenal glands exposed to nicotine and other chromaffin cell stimulants. J. Physiol. (Lond.) 179, 130–137 (1965).
— Rubin, R. P.: The role of calcium in the secretory response of the adrenal medulla to acetylcholine. J. Physiol. (Lond.) 159, 40–57 (1961).
— — The mechanism of catecholamine release from the adrenal medulla and the role of calcium in stimulus-secretion coupling. J. Physiol. (Lond.) 167, 288–310 (1963).
Ehinger, B., Falck, B., Persson, H., Rosengren, E., Sporrong, B.: Localization of acetylcholine in the feline iris. Acta physiol. scand. 58 P, Suppl. 330 (1969).
v. Euler, U. S., Lishajko, F.: Effect of adenine nucleotides on catecholamine release and uptake in isolated adrenergic nerve granules. Acta physiol. scand. 59, 454–461 (1963).
Folkow, B., Häggendal, J., Lisander, B.: Extent of release and elimination of noradrenaline at peripheral adrenergic terminals. Acta physiol. scand. 72, Suppl. 307 (1968).
Haefely, W., Hürliman, A., Thoener, H.: Relation between the rate of stimulation and the quantity of noradrenaline liberated from sympathetic nerve endings in the isolated perfused spleen of the cat. J. Physiol. (Lond.) 181, 48–58 (1965).
Häggendal, J., Malmfors, T.: The effect of nerve activity on the uptake of noradrenaline into the adrenergic nerve terminals. Acta physiol. scand. 75, 33–38 (1969).
Hedqvist, P.: Modulating effect of prostaglandin E2 on noradrenaline release from the isolated cat spleen. Acta physiol. scand. 75, 511–512 (1969).
Hökfelt, T.: Distribution of noradrenaline storing particles in peripheral adrenergic neurons as revealed by electron microscopy. Acta physiol. scand. 76, 427–440 (1969).
Horton, E. W.: Hypotheses on physiological roles of prostaglandins. Physiol. Rev. 49, 122–161 (1969).
Hukovic, S., Muscholl, E.: Die Noradrenalin-Abgabe aus dem isolierten Kaninchenherzen bei sympathischer Nervenreizung und ihre pharmakologische Beeinflussung. Naunyn- Schmiedebergs Arch. exp. Path. Pharmak. 244, 81–96 (1962).
Kanno, T., Douglas, W. W.: Effect of rapid application of acetylcholine or depolarising current on transmembrane potentials of adrenal chromaffin cells. Proc. Canad. Fed. biol. Soc. 10, 39 (1967).
Katz, B.: The release of neutral transmitter substances. The Sherrington Lectures X. Liverpool: University Press 1969.
— Miledi, R.: The quantal release of transmitter substances. Studies in Physiology, pp. 118 to 125. Berlin-Heidelberg-New York: Springer 1965.
— — The role of calcium in neuromuscular facilitation. J. Physiol. (Lond.) 195, 481–492 (1968).
Kirpekar, S. M., Cervoni, P.: Effect of cocaine, phenoxybenzamine and phentolamine on the catecholamine output from spleen and adrenal medulla. J. Pharmacol. exp. Ther. 142, 59–70 (1963).
— Misu, Y.: Release of noradrenaline by splenic nerve stimulation and its dependence on calcium. J. Physiol. (Lond.) 188, 219–234 (1967).
Kirshner, N., Sage, H. J., Smith, W. J.: Mechanism of secretion from the adrenal medulla. II. Release of catecholamines and storage vesicle protein in response to chemical stimulation. Molec. Pharmacol. 3, 254–265 (1967)
— Viveros, O. H.: Quantal Aspects of the secretion of catecholamines and dopamine-β-hydroxylase from the adrenal medulla. This volume, p. 78.
Kopin, I. J., Breese, G. R., Krauss, K. R., Weise, V. K.: Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J. Pharmacol. exp. Ther. 161, 271–278 (1968).
Krnjevic, K., Miledi, R.: Failure of neuromuscular propagation in rats. J. Physiol. (Lond.) 140, 440–461 (1958).
Lindmar, P., Löffelholz, K., Muscholl, E.: A muscarinic mechanism inhibiting the release of noradrenaline from peripheral adrenergic fibres by nicotinic agents. Brit. J. Pharmacol. 32, 280–294 (1968).
Löffelholz, K., Muscholl, E.: Die Hemmung der Noradrenalin-Abgabe durch Acetylcholin am sympatisch gereizten, isolierten Kaninchenherzen. Arch. int. Path. Pharmak. 263, 236 (1969).
Malamed, S., Poisner, A. M., Trifaro, J. M., Douglas, W. W.: The fate of the chromaffin granule during catecholamine release from the adrenal medulla. III. Recovery of a purified fraction of electrontranslucent structures. Biochem. Pharmacol. 17, 241–246 (1968).
Marley, E., Paton, W. D. M.: The output of sympathetic amines from the cat’s adrenal gland in response to splanchnic nerve activity. J. Physiol. (Lond.) 155, 1–27 (1961).
— Prout, G. I.: Physiology and pharmacology of the splanchnic adrenal medullary junction. J. Physiol. (Lond.) 180, 483–513 (1965).
Poisner, A. M., Trifaro, J. M., Douglas, W. W.: The fate of the chromaffin granule during catecholamine release from the adrenal medulla. II. Loss of protein and retention of lipid in subcellular fractions. Biochem. Pharmacol. 16, 2101–2108 (1967).
Potter, L. T.: Storage particles in noradrenergic tissues. Pharmacol. Rev. 18, 425–432 (1966).
Poulsen, J. H., Petersen, O. H.: Resting and secretory transmembrane potentials in the submandibular gland of the cat. Acta physiol. scand. 68. Suppl. 277, 166 (1966).
Rosell, S., Kopin, I. J., Axelrod, J.: Fate of H3-noradrenaline in skeletal muscle before and following sympathetic stimulation. Amer. J. Physiol. 205, 317–321 (1963).
Schild, H. O.: Effect of adrenaline on depolarized smooth nuscle. Ciba Foundation Symposium on Adrenergic Mechanism, pp. 288–292. (Vane, J. R., Wolstenholme, G. E. W., O’Connor, M., Eds.) London: Churchill Ltd. 1960.
Schümann, H. J.: Über den Noradrenalin- und ATP-Gehalt sympatischer Nerven. Naunyn- Schmiedebergs Arch. exp. Path. Pharmak. 233, 296–300 (1958).
Serck-Hanssen, G.: Chromogranin, a constituent of the chromaffin granule membrane. Acta physiol. scand. 63 P, Suppl. 330 (1969).
Stjärne, L.: Studies of catecholamine uptake, storage and release mechanism. Acta physiol. scand. 62, Suppl. 228 (1964).
— Storage particles in noradrenergic tissues. Pharmacol. Rev. 18, 432 (1966).
— Hedqvist, P.: Facilitation/summation and fading in catecholamine secretion from adrenal medulla and sympathetic nerves. To be published.
— — Bygdeman, S.: Neurotransmitter quantum released from sympathetic nerves in cat’s skeletal muscle. Life Sci. 8,189–196 (1969).
Stjärne, L., Hedqvist, P., Lagercrantz, H.: Catecholamines and adenine nucleotide material in effluent from stimulated adrenal medulla: a study of the exocytosis hypothesis for hormone secretion and neurotransmitter release. Biochem. Pharmacol. (In press.)
— Lishajko, F.: Localization of different steps in noradrenaline synthesis to different fractions of a bovine splenic nerve homogenate. Biochem. Pharmacol. 16, 1719–1728 (1967).
Viveros, O. H., Arqueros, L., Kirshner, N.: Release of catecholamines and dopamine- oxidase from the adrenal medulla. Life Sci. 7, 609–618 (1968).
— — — Quantal secretion from adrenal medulla: All-or-none release of storage vesicle content. Science 165, 911–913 (1969).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1970 Springer-Verlag
About this paper
Cite this paper
Stjärne, L. (1970). Quantal or Graded Secretion of Adrenal Medullary Hormone and Sympathetic Neurotransmitter. In: Schümann, HJ., Kroneberg, G. (eds) New Aspects of Storage and Release Mechanisms of Catecholamines. Bayer-Symposium, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46241-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-46241-2_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46243-6
Online ISBN: 978-3-642-46241-2
eBook Packages: Springer Book Archive